Khaled Abduljalil

Simulation of virtual human subjects to investigate the impact of

Lisa M. Almond, Khaled Abduljalil, K Rowland-Yeo, 2010 .

A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4.

Lu Gaohua, Amin Rostami-Hodjegan, Masoud Jamei, 2012, British journal of clinical pharmacology.

Deciding on Success Criteria for Predictability of Pharmacokinetic Parameters from In Vitro Studies: An Analysis Based on In Vivo Observations

Khaled Abduljalil, Amin Rostami-Hodjegan, A. Rostami-Hodjegan, 2014, Drug Metabolism and Disposition.

More Power to OATP1B1: An Evaluation of Sample Size in Pharmacogenetic Studies Using a Rosuvastatin PBPK Model for Intestinal, Hepatic, and Renal Transporter‐Mediated Clearances

Khaled Abduljalil, Sibylle Neuhoff, S. Neuhoff, 2016, Journal of clinical pharmacology.

Drug Dosing in Pregnant Women: Challenges and Opportunities in Using Physiologically Based Pharmacokinetic Modeling and Simulations

Khaled Abduljalil, Rick Greupink, R. Greupink, 2018, CPT: pharmacometrics & systems pharmacology.

Anatomical, Physiological and Metabolic Changes with Gestational Age during Normal Pregnancy

Amin Rostami-Hodjegan, Khaled Abduljalil, P. Furness, 2012, Clinical Pharmacokinetics.

Fetal Physiologically Based Pharmacokinetic Models: Systems Information on the Growth and Composition of Fetal Organs

Masoud Jamei, Khaled Abduljalil, M. Jamei, 2018, Clinical Pharmacokinetics.

Fetal Physiologically-Based Pharmacokinetic Models: Systems Information on Fetal Biometry and Gross Composition

Amin Rostami-Hodjegan, Khaled Abduljalil, A. Rostami-Hodjegan, 2018, Clinical Pharmacokinetics.